ClinConnect ClinConnect Logo
Search / Trial NCT06323603

Biomonitoring of Occupationally Populations Exposed to Micro and Nanoplastic

Launched by RICARD MARCOS · Mar 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Biomonitoring Genotoxic Damage Micro And Nanoplastic

ClinConnect Summary

This clinical trial is studying the effects of exposure to micro and nanoplastics on workers who handle plastics in their jobs. Researchers want to find out if being around these tiny plastic particles can cause damage to DNA and other health issues. The study is currently recruiting participants, specifically healthy adults who have been employed at their company for at least four years.

To be eligible, participants must be over 18 years old and have no serious health problems. They will need to provide written consent to join the study and must be willing to follow the study guidelines. If you join, you can expect to undergo some health checks, including a physical exam and tests to ensure your overall health. It’s important to note that if you've had an X-ray in the last three months or have any significant health concerns, you may not be able to participate. This trial aims to better understand the impact of plastic exposure on health, which is crucial for improving workplace safety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged over 18 years.
  • Healthy subjects defined by the absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, haematology, blood chemistry, and urine analysis.
  • Able to participate and willing to give written informed consent and to comply with the study restrictions.
  • Have been working at the company for the last 48 months
  • Exclusion Criteria:
  • Workers decline participation
  • Legal incapacity or inability to understand or comply with the requirements of the study.
  • Any hierarchical subordination to the PI
  • Clinically significant findings as determined by medical history taking, physical examination, ECG, and vital signs.
  • Submitted to X-ray in the three previous months

About Ricard Marcos

Ricard Marcos is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing groundbreaking therapies, the organization collaborates with leading healthcare professionals and institutions to conduct rigorous trials that adhere to the highest ethical and regulatory standards. Ricard Marcos emphasizes patient safety and data integrity, aiming to deliver impactful solutions that address unmet medical needs across various therapeutic areas. Their expertise in clinical development and a robust network of partnerships position them as a vital contributor to the evolution of healthcare.

Locations

Helsinki, , Finland

Alicante, , Spain

Alicante, , Spain

Barcelona, , Spain

Patients applied

0 patients applied

Trial Officials

Julia Catalan, Researcher

Principal Investigator

FIOH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported